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Mammary gland myoepithelial cells were isolated from cattle and cell lines were established. Cells were 
plated onto tissue culture dishes with or without collagen. Cells were transfected with bovine growth hor- 
mone rDNA containing one of the following eucaryotic transcriptional regulatory sequences: human cyto- 
megalovirus immediate early promoter, simian virus 40 early promoter, mouse metallothionein I promoter 
and the Rous sarcoma virus long terminal repeat. These sequences were evaluated for their ability to direct 
recombinant bovine growth hormone DNA expression in myoepithelial cells. The most effective transcrip- 
tional regulatory sequences were the cytomegalovirus immediate early and simian virus 40 early promoters. 
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1. INTRODUCTION 
The use of recombinant DNA technology has 
resulted in the cloning of a variety of growth hor- 
mone genes and cDNAs including those derived 
from human, rat, bovine, and porcine tissue [l--4]. 
Growth hormone genes have been expressed in 
both procaryotic and eucaryotic cells. DNAs com- 
plementary to human, bovine and porcine mRNA 
have been expressed in Escherichia coli [ 1,3]. Rat, 
human and bovine growth hormones have been ex- 
pressed in cultured mammalian cells [5-71. 
Pasleau et al. [8] demonstrated bovine growth 
hormone gene expression in rat GH3 cells, directed 
by the Rous sarcoma virus long terminal repeat 
and the cytomegalovirus immediate early pro- 
moter. No attempts have been made to direct 
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recombinant bovine growth hormone DNA expres- 
sion in specific mammary gland cell types using 
these eucaryotic viral promoters. 
For the possible use of recombinant-derived 
peptides, such as growth hormone in animal 
husbandry and medicine, we evaluated various 
eucaryotic transcriptional regulatory sequences for 
their ability to direct recombinant bovine growth 
hormone DNA expression in cultured bovine 
mammary gland, myoepithelial cells. 
2. MATERIALS AND METHODS 
Myoepithelial cells were originally isolated from 
mammary tissue of two lactating Holstein cows by 
collagenase dispersion of tissue and density gra- 
dient centrifugation [9]. Cell lines were established 
from primary cultures. Culture medium (main- 
tenance medium) consisted of Dulbecco’s modified 
Eagles medium containing 5% bovine serum col- 
lected from the cows at slaughter, 2.38 mg/ml 
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Fig. 1. Constructs of plasmid DNAs: (A) pCMVIE-bGHb, (B) pBGH-20, (C) pBGH-10 and (D) pBGH-5. All plasmids 
contain a BumHI-EcoRI fragment from the bGH gene [13,14]. Black boxes represent bGH exons and hatched lines 
represent pBR322 sequences containing the ampicillin-resistance gene (AMP) and the origin of replication (ORI). The 
‘TATA box’ for each promoter is indicated. Details of pCMVIE-bGHb and pBGH-5 constructions have been published 
[7,8]. The SV40 early promoter was ligated to the bGH gene as follows. pSV0 (from Peter Lomedico, Hoffmann La 
Roche) was cleaved with Hind111 and EcoRI and a 415 base pair fragment containing the SV40 early promoter was 
isolated. pBGH-2 DNA was cleaved with WI and BarnHI. All restriction endonucleases used in these cleavages generate 
5’-protruding termini. The ends were made flush by addition of deoxynucleotides using DNA polymerase 1. The 
resulting blunt end molecules were ligated and transfected into E. coli RR1 cells. A plasmid containing the SV40 early 
sequence attached to the bGH gene was isolated (pBGH-20). The mouse metallothionein I promoter was ligated to the 
bGH gene as follows: pMK DNA (from Palmiter, R.) was cleaved with BgnI and EcoRI and a 750 bp fragment 
containing the promoter isolated. Similarly, pBGH-2 was cleaved with EcoRI and BumHI and a 2.2 linear fragment 
isolated. pBR322 was linearized with EcoRI. Following a three-fragment ligation, E. coli RR1 cells were transfected 
using standard procedures. A plasmid containing the metallothionein I promoter ligated to the bGH gene was isolated 
(pBGH-10). 
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Hepes, 0.35 mg/ml L-glutamine, 0.2 mg/ml strep- 
tomycin and 0.2 U/ml penicillin. 
A transient eucaryotic expression assay system 
was employed. The technique used was as de- 
scribed in [7,8,10] with minor modifications. 
Briefly, approx. 5.0 x lo5 cells were plated onto 
35 mm plastic tissue culture plates in the absence 
or presence of bovine epidermal collagen (Vitrogen 
100, Collagen Corp., Palo Alto, CA) in 
maintenance medium, pH 7.4). Following an over- 
night incubation, cells were transfected with 
bovine growth hormone genomic (bGH) rDNA 
(1 pg) and DEAE-dextran (20 pg) in phosphate- 
buffered saline, containing one of the following 
eucaryotic promoters shown in fig.1: human 
cytomegalovirus immediate early promoter 
(pCMVIE-bGHb), simian virus 40 early promoter 
(pBGH-20), the mouse metallothionein I promoter 
(pBGH-10) and the Rous sarcoma virus long ter- 
minal repeat (pBGH-5). In these plasmid construc- 
tions the bovine growth hormone 5 ‘-flanking 
sequences were removed and replaced by the 
various eucaryotic promoters. 
After incubation with the respective plasmids, 
cells were washed three times with Dulbecco’s 
medium without serum. Cells treated with 
pCMVIE-bGHb, pBGH-5 and pBGH-20 were 
then incubated in maintenance medium. Cells 
treated with the mouse metallothionein I promoter 
bGH DNA were divided into 2 treatment groups. 
One group of cultures was incubated with medium 
containing 5% bovine serum and 100pM ZnClz, 
the other being incubated with Dulbecco’s medium 
containing 5% bovine serum without ZnClz. ZnClz 
was used to activate the metallothionein I pro- 
moter. Medium was collected every 24 h for 3 days 
and then every 3rd day for 28 days. Bovine growth 
hormone in medium was determined by radioim- 
munoassay [ 111. The concentration of bovine 
growth hormone was determined in fresh 
maintenance medium. The growth hormone con- 
centrations measured from cells post-transfection 
were all adjusted. This was done by subtracting the 
bGH concentration contained in the maintenance 
medium from them. 
3. RESULTS 
pCMVIE-bGHb acted as a potent regulatory se- 
quence in directing bGH gene expression in 
myoepithelial cell lines (table 1). Cells showed 
maximum gene expression on day 7 post- 
transfection. At this time, the peak concentration 
of bGH was 59.2 ng/ml in medium from cells 
grown on plastic and 115 ng/ml in medium of cells 
grown on collagen. 
Concentrations of bGH in medium from cells 
cultured on collagen were almost 2-times greater 
than those found in medium from cells cultured on 
plastic. Concentrations of bGH remained elevated 
in cells grown on both substrates up to 25 days 
post-transfection (table 1). 
pBGH-20 was also effective in directing bGH 
gene expression in myoepithelial cells (table 1). 
Concentrations of bGH fluctuated somewhat from 
days 7 to 16 (17-122 ng/ml), but peaks in bGH 
were reached during this time interval. Concentra- 
tions of bGH in medium from cells cultured on 
plastic were nearly 3-times greater than those 
found in medium from cells grown on collagen. 
Growth hormone concentrations remained 
elevated for up to 25 days post-transfection for 
cells grown on plastic (table 1). 
pBGH-10 and pBGH-5 were ineffective in di- 
recting gene expression in mammary myoepithelial 
cell lines (table 1). 
4. DISCUSSION 
Pasleau et al. [8] have shown that the 
cytomegalovirus immediate early gene regulatory 
region was 3-4-fold more efficient than the Rous 
sarcoma retroviral long terminal repeat in directing 
expression of the bovine growth hormone gene in 
rat GH3 cells. These promoters as well as the 
simian virus 40 early and mouse metallothionein I
were tested for their ability to direct a ‘reporter’ 
gene (bGH) in bovine mammary epithelial cells. 
The cytomegalovirus immediate early promoter 
and the simian viral 40 early promoter were effec- 
tive in directing gene expression in mammary 
myoepithelial cells, while the Rous sarcoma virus 
long terminal repeat and mouse metallothionein I
promoters were not. The concentrations of bGH in 
medium were highest for cells transfected with the 
pCMVIE-bGHb DNA when cultured on collagen. 
The simian viral promoter appeared more effective 
in expressing bGH when it was introduced into 
myoepithelial cells cultured on plastic. We have 
shown that the fine structure of the bovine mam- 
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mar-y myoepithelial cell can change depending on 
the substrate on which it is cultured [12]. 
Our data support the fact that eucaryotic 
transcriptional regulatory sequences, used to ex- 
press recombinant derived genes in higher 
eucaryotic cells, are cell specific. Furthermore, the 
matrix on which the cells are grown and the degree 
of their subcellular differentiation, at the time of 
plasmid insertion, may be important factors to 
consider when introducing recombinant derived 
genetic material into higher eucaryotic cells. 
The techniques described here will be useful in 
studying the physiological and biochemical 
mechanisms whereby mammotropic agents such as 
growth hormone influence the development and 
function of the mammary gland. 
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